McCaul, Van Hollen, Speier, Reed, and Capito Introduce Bipartisan Childhood Cancer STAR Act link to press release WASHINGTON, DC – Today Congressman Michael McCaul introduced the bipartisan, bicameral Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act of 2015. Congressman McCaul was joined by his fellow co-chair of the Childhood…
“They were told it was a ‘rare’ brain tumor, and that nothing had been done for decades, in research, because the ‘numbers’ weren’t great enough for investors. After his death, they came to learn that DIPG is one of the more common pediatric brain tumors(12% incidence), and responsible for roughly…
This letter is being sent to California State Representatives 8/3/2015 Dear Senator Runner, As you may very well know, currently there is a National Movement for greater Childhood Cancer Awareness. The leading disease-cause of death for children in our country, pediatric cancer, is one of the least-funded areas of…
This important article is featured in Frontiers in Oncology, part of the research topic, “Advances in Diffuse Intrinsic Pontine Glioma”, accessible here giving full credit to sources; the article appears here as it was written. Link to Article MINI REVIEW ARTICLE Front. Oncol., 01 July 2015 | http://dx.doi.org/10.3389/fonc.2015.00148 Future clinical…
Please help us get a National Day for our DIPG heroes! This could seriously help our kids and childhood cancer research. That’s right, you really do have the power to create change! All it takes is clicking a button, but you have to actually do it for it to work,…
POST-Run VIDEO:
Pre-Run VIDEO:
The DIPG Awareness Run on May 25, 2015 marked the beginning of the first celebrated DIPG Awareness Week in the State of California. Declared in June of 2014 by the California State Assembly, thanks to the work of Assemblyman Scott Wilk, a national statement and achievement was made for DIPG,…
Wednesday, May 20, Santa Clarita, CA–DIPG, diffuse intrinsic pontine glioma, is a pediatric brain tumor that is invariably terminal with no progress made to that effect in over 35 years of clinical record. DIPG is responsible for roughly 80% of pediatric brain tumor deaths annually[1], the leading cause of cancer-related…
